VEGFA and neoplasm: Supporting their potential importance in the response of the tumor to therapy, Shojaei and Ferrara reported that the recruitment of bone marrow-derived GR1+ myeloid cells resulted in a tumor that was refractory to treatment with inhibitors of VEGF [76].